You are here: Home »
Product
»
Weak Base Anion Exchange Resin
»
SEPLITE® LX6702 Mixed base anion resins
SEPLITE® LX6702 Mixed base anion resins
Scan the QR code
Acrylic, gel type, mixed base anion resins
SEPLITE® LX6702 Mixed base anion resins Weak Base Anion Exchange Resin
Descriptions:
SEPLITE® LX6702 is an acrylic, gel type anionic resins containing both weak and strong base groups.
The acrylic matrix ensures its feature of superior removal of organic substances from water or other similar solutions.
The mixed base of LX6702 makes this resin suitable for removal of both strong and weak acids from solutions.
This resin also shows excellent osmotic shock and anti-fouling performance during operation.
Physical and Chemical Characteristics:
Matrix | Gel type acrylic copolymer |
Physical Appearance | spheres |
Shipping form | Cl |
Particle range | 0.40-1.25mm (≥95%) |
Bulk density | 0.65-0.75 g/ml |
Density | 1.05-1.15 g/ml |
Total capacity | ≥1.25 eq/ L |
Moisture Content | 60-70% |
Whole beads count | ≥95% |
Precautions:
Resins should be stored in sealed containers or bags where temperature was above 0℃ in dry conditions without exposure to direct sunlight.
Do not mix ion exchange resin with strong oxidizing agents; otherwise it will cause violent reactions.
In case of eyes contact with resins, rinse eyes immediately with plenty of water, and consult a specialist.
Material and samples must be disposed according to local regulations.
Dry polymers will expand when become wetted and may cause an exothermic reaction.
Spilled materials may be slippery.
SEPLITE® and Monojet™ are registered trademarks of Sunresin New Materials Co. Ltd.
Free Quote
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
11
2025 04
SZSE Visits Sunresin – An ETF Constituent Company in the CSI 500 Index
On the morning of March 28, the Shenzhen Stock Exchange (SZSE), along with representatives from Harvest Fund and over 30 other participants, visited Sunresin— a constituent company of the CSI 500 Index — for a special research and engagement activity.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit